Trazium

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Trazium
Trazium.png
Systematic (IUPAC) name
1-(4-chlorophenyl)-1-hydroxy-1,4-dihydro[1,2,4]triazino[6,1-a]isoquinolin-5-ium
Clinical data
Legal status
  • Uncontrolled
Routes Oral
Identifiers
CAS number 97110-59-3
ATC code None
PubChem CID 72166
ChemSpider 65139
Chemical data
Formula C17H13ClN3O 
Molecular mass 310.76 g/mol

Trazium (EGYT-3,615) is an antidepressant drug which was never marketed.[1] It has psychostimulant-like effects and its actions appear to be mediated by the dopaminergic and adrenergic systems.[2]

References[edit]

  1. ^ David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9. 
  2. ^ Gyertyán I, Petöcz L, Bajnógel J, et al. (July 1989). "Possible involvement of the dopaminergic system in the mode of action of the potential antidepressant trazium esilate". Arzneimittel-Forschung 39 (7): 775–81. PMID 2551306.